UMIN-CTR Clinical Trial
| Unique ID issued by UMIN | UMIN000022777 |
|---|---|
| Receipt number | R000026253 |
| Scientific Title | Plasma xantine oxidoreductase (XOR) activity in patients with acute myocardial infarction |
| Date of disclosure of the study information | 2016/06/17 |
| Last modified on | 2021/06/21 12:22:48 |
* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments
Basic information
Public title
Plasma xantine oxidoreductase (XOR) activity in patients with acute myocardial infarction
Acronym
Acute myocardial infarction and plasma XOR activity
Scientific Title
Plasma xantine oxidoreductase (XOR) activity in patients with acute myocardial infarction
Scientific Title:Acronym
Acute myocardial infarction and plasma XOR activity
Region
| Japan |
Condition
Condition
Acute myocardial infarction
Classification by specialty
| Cardiology |
Classification by malignancy
Others
Genomic information
NO
Objectives
Narrative objectives1
To evaluate the clinical significance of plasma xantine oxidoreductase levels in patients with acute myocardial infarction.
Basic objectives2
Bio-equivalence
Basic objectives -Others
Trial characteristics_1
Trial characteristics_2
Developmental phase
Assessment
Primary outcomes
Relationships between plasma xantine oxidoreductase activity and prognosis in patients with acute myocardial infarction
Key secondary outcomes
Base
Study type
Observational
Study design
Basic design
Randomization
Randomization unit
Blinding
Control
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment
Intervention
No. of arms
Purpose of intervention
Type of intervention
Interventions/Control_1
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10
Eligibility
Age-lower limit
| 20 | years-old | <= |
Age-upper limit
| 100 | years-old | > |
Gender
Male and Female
Key inclusion criteria
1)Patiets who admitted to our hospital diagnosed with acute myocardial infarction and emergent coronary intervention was performed.
2)Patients who give written informed consent.
Key exclusion criteria
1)Patinets who the physician judged to be inappropriate to this study.
2)The patient who withdrew informed consent.
Target sample size
30
Research contact person
Name of lead principal investigator
| 1st name | Hiroaki |
| Middle name | |
| Last name | Yokoyama |
Organization
Hirosaki University Graduate School of Medicine
Division name
Department of Cardiology
Zip code
036-8562
Address
5 Zaifu-cho Hirosaki, Aomori
TEL
0172-39-5057
hero8686@hirosaki-u.ac.jp
Public contact
Name of contact person
| 1st name | Hiroaki |
| Middle name | |
| Last name | Yokoyama |
Organization
Hirosaki University Graduate School of Medicine
Division name
Department of Cardiology
Zip code
036-8562
Address
5 Zaifu-cho Hirosaki, Aomori
TEL
0172-39-5057
Homepage URL
hero8686@hirosaki-u.ac.jp
Sponsor or person
Institute
Department of Cardiology, Hirosaki University Graduate School of Medicine
Institute
Department
Personal name
Funding Source
Organization
Hirosaki University Hospital
Organization
Division
Category of Funding Organization
Other
Nationality of Funding Organization
Other related organizations
Co-sponsor
Sanwa Kagaku Kenkyusyo Co., Ltd.
Name of secondary funder(s)
IRB Contact (For public release)
Organization
Hirosaki University Certified Review Board
Address
1 Bunkyo-sho, Hirosaki
Tel
0172-39-5362
crb-hirosaki@hirosaki-u.ac.jp
Secondary IDs
Secondary IDs
NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW
Institutions
Institutions
弘前大学医学部附属病院(青森県)
Other administrative information
Date of disclosure of the study information
| 2016 | Year | 06 | Month | 17 | Day |
Related information
URL releasing protocol
Publication of results
Unpublished
Result
URL related to results and publications
Number of participants that the trial has enrolled
50
Results
Results date posted
Results Delayed
| Delay expected |
Results Delay Reason
Under making Manuscript.
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description
Progress
Recruitment status
No longer recruiting
Date of protocol fixation
| 2016 | Year | 01 | Month | 14 | Day |
Date of IRB
| 2016 | Year | 04 | Month | 04 | Day |
Anticipated trial start date
| 2016 | Year | 04 | Month | 04 | Day |
Last follow-up date
| 2020 | Year | 03 | Month | 31 | Day |
Date of closure to data entry
Date trial data considered complete
Date analysis concluded
Other
Other related information
Study design: Observation
Objective recruitment: Patients who admitted to our hospital diagnosed with acute myocardial infarction and emergent coronary intervention was performed.
Primary outcome: Relationships between plasma xantine oxidoreductase activity and prognosis in patients with acute myocardial infarction.
Management information
Registered date
| 2016 | Year | 06 | Month | 17 | Day |
Last modified on
| 2021 | Year | 06 | Month | 21 | Day |
Link to view the page
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000026253
